Richard K Matros (Chair, CEO and President) sold ~$4.17M of Sabra Health Care REIT
Scheduled in advanceLoading…
SBRA · NASDAQ · Health Care REITs
Health Care REITs company.
In the last 90 days, no insider of Sabra Health Care REIT reported an open-market purchase and 1 open-market sale worth about $4.17M. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$19.07
Last 12 months
Not enough history
Market value
$4.87B
Revenue
$236M
+24.7% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
$2.39B
Debt $2.63B, cash $232M, at Jun 30, 2026
Net income, last 12 months
$65.4M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 3, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
1 sale
$4.17M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$775M
+10.2% vs the year before
Net income, fiscal 2025
$156M
As reported in the annual filing
Shares outstanding
255M
As of Jul 27, 2026
In fiscal 2025 the company spent $289M on dividends. Cash actually paid, from its cash-flow statement.
Traded Mar 25 · filed 2 days laterNot under a reported trading plan
Since filing −3.9% · S&P 500 +18.0% · to Oct 5
Sabra Health Care REIT's Executive VP & CAO sold $302K of Sabra Health Care REIT shares. The filing does not indicate a pre-arranged trading plan.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $17.90 on Oct 6, 2025 to $19.07 on Oct 5, 2026 (+6.5%). Disclosed activity in the last 12 months: 0 insider purchases, 2 insider sales (1 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
Top officer leaving
“Nevo-Hacohen’s retirement, Michael Costa was appointed by the Board to serve as the Company’s Treasurer (in addition to continuing to serve as the Company’s Executive Vice President and Chief Financial Officer) effective January 1, 2026, until his successor is duly elected and qualifies.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.